Thanks for the correction, but it was already correct. Menopur contains the equivalent of 75 IU of “LH activity”, which is not necessarily the same thing as LH. That mainly comes from the low levels of hCG, but there is also some residual LH, too.
hCG and LH activate the same receptors in the ovaries, so hCG is described as “LH activity”. The hCG is more potent, and longer-lasting too.
This is how the Ferring drug reps describe it when they come to the clinic. It’s also known pretty well within the industry.
It’s not mentioned in every description of Menopur, but it in mentioned in some. Here is one example:
Clinical Merit of Menopur in IVF
“…MENOPUR, a treatment containing both FSH (follicle stimulating hormone) and hCG-driven (human chorionic gonadotrophin) LH-activity…”
There’s more to be said, but that should suffice.